Şunu aradınız:: for the treatment of abdominal aortic aneu... (Danca - Portekizce)

m01ah for the short- term treatment of postoperative pain
m01ah for the short- term treatment of postoperative pain

clinical investigation of medicinal products for the treatment of bipolar disorder
clinical investigation of medicinal products for the treatment of bipolar disorder

clinical investigation of medicinal products for the treatment of acute ischemic stroke
clinical investigation of medicinal products for the treatment of acute ischemic stroke

clinical investigation of medicinal products for prevention and the treatment of osteoporosis in men
clinical investigation of medicinal products for prevention and the treatment of osteoporosis in men

clinical investigation of medicinal products for the treatment of unstable coronary artery disease
clinical investigation of medicinal products for the treatment of unstable coronary artery disease

clinical investigation of medicinal products used in the treatment of osteoarthritis
pontos a considerar clinical investigation of medicinal products used in the treatment of osteoarthritis

clinical investigation of medicinal products for the treatment of cardiac failure (revision)
clinical investigation of medicinal products for the treatment of cardiac failure (revision)

note for guidance on clinical investigation of medicinal products for the treatment and prevention of bipolar disorder
note for guidance on clinical investigation of medicinal products for the treatment and prevention of bipolar disorder

note for guidance on clinical investigation of medicinal products for the treatment of peripheral arterial occlusive disease
of medicinal products for the treatment of peripheral arterial occlusive disease

clinical investigation of medicinal products for the treatment of peripheral arterial occlusive disease (revision)
clinical investigation of medicinal products for the treatment of peripheral arterial occlusive disease (revision)

concept paper on the development of a cpmp note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia
concept paper on the development of a cpmp note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia

concept paper on the development of a cpmp note for guidance on the clinical investigation of medicinal products in the treatment of asthma
investigation of medicinal products in the treatment of asthma concept paper on the development of a cpmp points to consider on biostatistical/ methodological issues arising

clinical investigation of medicinal products in the treatment of patients with chronic obstructive pulmonary disease
clinical investigation of medicinal products in the treatment of patients with chronic obstructive pulmonary disease

concept paper on the development of a cpmp note for guidance on clinical investigation of medicinal products for the treatment of generalised anxiety disorder
note for guidance on clinical investigation of medicinal products for treatment of nociceptive pain concept paper on the development of a cpmp note for guidance on clinical investigation of medicinal products for the treatment of generalised anxiety disorder

clinical investigation of medicinal products for prophylactic the treatment of peri - and post- operative venous thrombo- embolic risk
clinical investigation of medicinal products for prophylactic the treatment of peri - and post- operative venous thrombo- embolic risk

concept paper on the development of an addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure
concept paper on the development of an addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure

concept paper on the development of an appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia
concept paper on the development of an appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia

the use of botulinum toxin type- b in the treatment of patients who have become unresponsive to botulinum toxin type- a -- initial experiences.
the use of botulinum toxin type- b in the treatment of patients who have become unresponsive to botulinum toxin type- a -- initial experiences.

referencenummer titel på dokumentet (cpmp/ ewp/ 785/ 97) points to consider on the evaluation of medicinal products for the treatment of irritable bowel syndrome.
(cpmp/ ewp/ 785/ 97)

settlement of payment orders in the queue ( 1 ) the treatment of payment orders placed in queues depends on the priority class to which it was designated by the instructing participant .
settlement of payment orders in the queue ( 1 ) the treatment of payment orders placed in queues depends on the priority class to which it was designated by the instructing participant .